Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

S&P Industrial Sector Intl SPDR (IPN)

S&P Industrial Sector Intl SPDR (IPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC) Newswire.ca - Mon Nov 13, 2023

/CNW/ -- Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, rare disease and...

IPN : 34.71 (-0.54%)
IPSEY : 30.8000 (+2.46%)
Ipsen Receives CHMP Negative Opinion for Palovarotene as a Treatment for Fibrodysplasia Ossificans Progressiva in E.U. Business Wire - Fri Jan 27, 2023

Regulatory News:

OTC.VN : 0.325 (+3.17%)
IPN : 34.71 (-0.54%)
IPSEY : 30.8000 (+2.46%)
Ipsen Presents Phase III NAPOLI 3 Trial of Onivyde® Regimen Demonstrating Positive Survival Results in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma at ASCO GI Business Wire - Fri Jan 20, 2023

Regulatory News:

OTC.VN : 0.325 (+3.17%)
IPN : 34.71 (-0.54%)
IPSEY : 30.8000 (+2.46%)
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases Business Wire - Mon Jan 9, 2023

Regulatory News:

OTC.VN : 0.325 (+3.17%)
ALBO : 44.15 (-0.23%)
IPN : 34.71 (-0.54%)
IPSEY : 30.8000 (+2.46%)
Ipsen receives Complete Response Letter for palovarotene, an investigational treatment for fibrodysplasia ossificans progressiva Business Wire - Fri Dec 23, 2022

Regulatory News:

OTC.VN : 0.325 (+3.17%)
IPN : 34.71 (-0.54%)
IPSEY : 30.8000 (+2.46%)
Ipsen Provides Update On Phase III CONTACT-01 Trial Evaluating Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Non-small Cell Lung Cancer Previously Treated With Immunotherapy and Chemotherapy Business Wire - Thu Dec 8, 2022

Regulatory News:

OTC.VN : 0.325 (+3.17%)
IPN : 34.71 (-0.54%)
IPSEY : 30.8000 (+2.46%)
Onivyde® Regimen Demonstrated Statistically Significant Improvement in Overall Survival in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma Business Wire - Wed Nov 9, 2022

Regulatory News:

OTC.VN : 0.325 (+3.17%)
IPN : 34.71 (-0.54%)
IPSEY : 30.8000 (+2.46%)
Ipsen Delivers Strong Sales Growth in the First Nine Months of 2022 and Confirms Its Full-year Guidance Business Wire - Wed Oct 26, 2022

Regulatory News:

OTC.VN : 0.325 (+3.17%)
IPN : 34.71 (-0.54%)
IPSEY : 30.8000 (+2.46%)
Ipsen Statement on Updated Timeline for Palovarotene FDA Advisory Committee Meeting Business Wire - Tue Oct 25, 2022

Regulatory News:

OTC.VN : 0.325 (+3.17%)
IPN : 34.71 (-0.54%)
IPSEY : 30.8000 (+2.46%)
Ipsen Completes Acquisition of Epizyme Expanding Its Portfolio in Oncology Business Wire - Fri Aug 12, 2022

Regulatory News:

OTC.VN : 0.325 (+3.17%)
IPN : 34.71 (-0.54%)
IPSEY : 30.8000 (+2.46%)

Barchart Exclusives

3 Energy Dividend Stocks to Invest in Oil's 'Higher for Longer' Scenario Barchart - Thu May 2, 6:30PM CDT
Discover how Schlumberger, Baker Hughes, and Halliburton are leveraging their robust financial health and strategic initiatives to thrive in a market where oil prices are expected to remain elevated, in our latest deep dive into the energy sector's top performers. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot